Compare IDXX & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDXX | A |
|---|---|---|
| Founded | 1983 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.4B | 38.0B |
| IPO Year | 1996 | 1999 |
| Metric | IDXX | A |
|---|---|---|
| Price | $559.49 | $153.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 15 |
| Target Price | ★ $721.67 | $161.47 |
| AVG Volume (30 Days) | 612.4K | ★ 1.3M |
| Earning Date | 05-05-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | ★ 22.59 | 3.16 |
| EPS | ★ 7.74 | 2.27 |
| Revenue | $4,303,702,000.00 | ★ $4,472,000,000.00 |
| Revenue This Year | $10.88 | $8.45 |
| Revenue Next Year | $8.59 | $6.13 |
| P/E Ratio | $71.95 | ★ $70.01 |
| Revenue Growth | ★ 10.42 | 6.43 |
| 52 Week Low | $518.55 | $108.35 |
| 52 Week High | $769.98 | $160.51 |
| Indicator | IDXX | A |
|---|---|---|
| Relative Strength Index (RSI) | 47.93 | 63.85 |
| Support Level | $536.34 | $135.76 |
| Resistance Level | $583.93 | $160.27 |
| Average True Range (ATR) | 17.11 | 3.75 |
| MACD | -2.68 | 0.66 |
| Stochastic Oscillator | 30.11 | 65.26 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.